The outcome of Brighter's rights issue, announced on
"Brighter has successfully completed a rights issue that strengthens the company financially and provides resources for wide-scale commercialization of Actiste. The rights issue was designed to enable as many shareholders as possible to participate and subscribe for shares, as well as to execute a very cost-efficient capital raise. Thanks to the great interest to participate, Brighter now has the financial resources to move forward in accordance with our plan," says Henrik Norström, Brighter's CEO.
95 673 156 new shares are issued in this rights issue. The total number of shares in the company after the issue amounts to 191 784 360. The share capital increases by
Trading with BTA will take place on Nasdaq First North Growth Market until the conversion of BTA into ordinary shares, which is expected to take place week 5, 2020.
For further information, please contact:
Phone: +46 708 37 21 23
Email: ann.zetterberg@brighter.se
Henrik Norström, CEO
Phone: +46 733 40 30 45
Email: henrik.norstrom@brighter.se
About
Brighter is a health-tech company from
The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter's Certified Adviser is
This information is information that
https://news.cision.com/brighter-ab--publ-/r/99-54-percent-subscription-rate-in-brighter-s-rights-issue---corresponding-to-sek-191-million,c3008602
https://mb.cision.com/Main/13292/3008602/1174192.pdf
(c) 2020 Cision. All rights reserved., source